Maynard Um
-
-
-
-
-
-
-
BTIG on Mereo BipPharma Group (MREO): BMD improvements could lead to 'value-creating event'
-
-
-
-
-
-
-
Jefferies Downgrades Mereo BipPharma Group (MREO) to Hold
-
-
-
-
-
-
-
Ultragenyx Pharma (RARE) PT Lowered to $50 (from $103) at Citi
-
-
-
-
-
-
-
ashibio licenses vantictumab from Mereo for rare bone disorder treatment
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Mereo BipPharma Group (MREO)
-
-
-
-
-
-
-
Mereo BioPharma (MREO) Files for 26.64M Share Offering by Selling Stockholders
-
-
-
-
-
-
-
Mereo BipPharma Group (MREO) PT Raised to $7 at Needham
435,816 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

